Primacy of cardiac chymase over angiotensin converting enzyme as an angiotensin-(1-12) metabolizing enzyme

被引:39
作者
Ahmad, Sarfaraz [1 ]
Varagic, Jasmina [1 ,2 ]
VonCannon, Jessica L. [2 ]
Groban, Leanne [2 ,3 ,4 ]
Collawn, James F. [7 ]
Dell'Italia, Louis J. [8 ]
Ferrario, Carlos M. [1 ,5 ,6 ]
机构
[1] Wake Forest Univ, Sch Med, Gen Surg, Winston Salem, NC 27109 USA
[2] Wake Forest Univ, Sch Med, Hypertens & Vasc Res Ctr, Winston Salem, NC 27109 USA
[3] Wake Forest Univ, Sch Med, Anesthesiol, Winston Salem, NC 27109 USA
[4] Wake Forest Univ, Sch Med, Internal Med Mol Med, Winston Salem, NC 27109 USA
[5] Wake Forest Univ, Sch Med, Internal Med Nephrol, Winston Salem, NC 27109 USA
[6] Wake Forest Univ, Sch Med, Internal Med Cardiovasc Med, Winston Salem, NC 27109 USA
[7] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA
[8] Univ Alabama Birmingham, Dept Med, Div Cardiovasc Dis, Birmingham VA Med Ctr, Birmingham, AL 35294 USA
关键词
Rat cardiac chymase; Angiotensin-converting enzyme; Angiotensin-(1-12); Angiotensin I; Angiotensin II; Renin-angiotensin system; BLOOD-PRESSURE; II GENERATION; HIGH-GLUCOSE; SYSTEM; HEART; RATS; PROANGIOTENSIN-12; RECEPTOR; PEPTIDE; LOCALIZATION;
D O I
10.1016/j.bbrc.2016.07.100
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We showed previously that rat angiotensin-(1-12) [Ang-(1-12)] is metabolized by chymase and angiotensin converting enzyme (ACE) to generate Angiotensin II (Ang II). Here, we investigated the affinity of cardiac chymase and ACE enzymes for Ang-(1-12) and Angiotensin I (Ang I) substrates. Native plasma membranes (PMs) isolated from heart and lung tissues of adult spontaneously hypertensive rats (SHR) were incubated with radiolabeled I-125-Ang-(1-12) or I-125-Ang I, in the absence or presence of a chymase or ACE inhibitor (chymostatin and lisinopril, respectively). Products were quantitated by HPLC connected to an in-line flow-through gamma detector. The rate of I-125-Ang II formation from I-125-Ang-(1-12) by chymase was significantly higher (heart: 7.0 +/- 0.6 fmol/min/mg; lung: 33 +/- 1.2 fmol/min/mg, P < 0.001) when compared to I-125-Ang I substrate (heart: 0.8 +/- 0.1 fmol/min/mg; lung: 2.1 +/- 0.1 fmol/min/mg). Substrate affinity of I-125-Ang-(1-12) for rat cardiac chymase was also confirmed using excess unlabeled Ang-(1-12) or Ang I (0-250 mu M). The rate of I-125-Ang II formation was significantly lower using unlabeled Ang-(1-12) compared to unlabeled Ang I substrate. Kinetic data showed that rat chymase has a lower K-m (64 +/- 63 mu M vs 142 +/- 17 mu M), higher V-max (132 +/- 1.3 mu M/min/mg vs 1.9 +/- 0.2 mu M/min/mg) and more than 15-fold higher catalytic efficiency (ratio of V-max/K-m) for Ang-(1-12) compared to Ang I substrate, respectively. We also investigated ACE mediated hydrolysis of I-125-Ang-(1-12) and I-125-Ang I in solubilized membrane fractions of the SHR heart and lung. Interestingly, no significant difference in I-125-Ang II formation by ACE was detected using either substrate, I-125-Ang-(1-12) or I-125-Ang I, both in the heart (1.8 +/- 0.2 fmol/min/mg and 1.8 +/- 0.3 fmol/min/mg, respectively) and in the lungs (239 +/- 25 fmol/min/mg and 248 +/- 34 fmol/min/mg, respectively). Compared to chymase, ACE-mediated Ang-(1-12) metabolism in the heart was several fold lower. Overall our findings suggest that Ang-(1-12), not Ang I, is the better substrate for Ang II formation by chymase in adult rats. In addition, this confirms our previous observation that chymase (rather than ACE) is the main hydrolyzing enzyme responsible for Ang II generation from Ang-(1-12) in the adult rat heart. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码:559 / 564
页数:6
相关论文
共 50 条
  • [21] Cardiac angiotensin-(1-12) expression and systemic hypertension in rats expressing the human angiotensinogen gene
    Ferrario, Carlos M.
    VonCannon, Jessica
    Jiao, Yan
    Ahmad, Sarfaraz
    Bader, Michael
    Dell'Italia, Louis J.
    Groban, Leanne
    Varagic, Jasmina
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2016, 310 (08): : H995 - H1002
  • [22] Chymase-Dependent Generation of Angiotensin II from Angiotensin-(1-12) in Human Atrial Tissue
    Ahmad, Sarfaraz
    Simmons, Tony
    Varagic, Jasmina
    Moniwa, Norihito
    Chappell, Mark C.
    Ferrario, Carlos M.
    PLOS ONE, 2011, 6 (12):
  • [23] CARDIAC ANGIOTENSIN-II FORMATION - THE ANGIOTENSIN-I CONVERTING-ENZYME AND HUMAN CHYMASE
    URATA, H
    GANTEN, D
    EUROPEAN HEART JOURNAL, 1993, 14 : 177 - 182
  • [24] Angiotensin converting enzyme 2 and the kidney
    Ortiz-Melo, David I.
    Gurley, Susan B.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2016, 25 (01) : 59 - 66
  • [25] Atrial angiotensin-(1-12)/chymase expression data in patient of heart diseases
    Wang, Hao
    Varagic, Jasmina
    Nagata, Sayaka
    Kon, Neal D.
    Ahmad, Sarfaraz
    VonCannon, Jessica L.
    Wright, Kendra N.
    Sun, Xuming
    Deal, Dwight
    Groban, Leanne
    Ferrario, Carlos M.
    DATA IN BRIEF, 2020, 31
  • [26] Critical role of the chymase/angiotensin-(1-12) axis in modulating cardiomyocyte contractility
    Li, Tiankai
    Zhang, Xiaowei
    Cheng, Heng-Jie
    Zhang, Zhi
    Ahmad, Sarfaraz
    Varagic, Jasmina
    Li, Weimin
    Cheng, Che Ping
    Ferrario, Carlos M.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 264 : 137 - 144
  • [27] Angiotensin converting enzyme 2 and atherosclerosis
    Wang, Yutang
    Tikellis, Chris
    Thomas, Merlin C.
    Golledge, Jonathan
    ATHEROSCLEROSIS, 2013, 226 (01) : 3 - 8
  • [28] Angiotensin-(1-7) with Thioether Bridge: An Angiotensin-Converting Enzyme-Resistant, Potent Angiotensin-(1-7) Analog
    Kluskens, Leon D.
    Nelemans, S. Adriaan
    Rink, Rick
    de Vries, Louwe
    Meter-Arkema, Anita
    Wang, Yong
    Walther, Thomas
    Kuipers, Anneke
    Moll, Gert N.
    Haas, Marijke
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 328 (03) : 849 - 854
  • [29] Cardioprotective role for angiotensin-(1-7) and angiotensin converting enzyme 2 in the heart
    Tallant, E. Ann
    Ferrario, Carlos M.
    Gallagher, Patricia E.
    FUTURE CARDIOLOGY, 2006, 2 (03) : 335 - 342
  • [30] Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism
    Meurs, Kathryn M.
    Stern, Joshua A.
    Atkins, Clarke E.
    Adin, Darcy
    Aona, Brent
    Condit, Julia
    DeFrancesco, Teresa
    Reina-Doreste, Yamir
    Keene, Bruce W.
    Tou, Sandy
    Ward, Jessica
    Woodruff, Kathleen
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2017, 18 (04) : 1 - 4